Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction
Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley
Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley
View: Text | PDF
Research Article Cardiology Immunology

iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction

  • Text
  • PDF
Abstract

The role of proinflammation, and specifically TNF-α, on downstream fibrosis and healing after cardiac injury remains unknown. Using iRhom2-deficient mice, which lack myeloid-specific shedding of TNF-α, we reveal increased macrophages (MΦs) that were skewed towards a more proinflammatory (M1) state at day 4, followed by more reparative, antiinflammatory (M2) state at day 7 after myocardial infarction (MI). However, associated functional cytokine expression was significantly reduced in iRhom2-mutant M1 and M2 MΦs, respectively. A dampened proinflammatory signature in iRhom2-deficient mice during the acute phase of injury and subsequent changes in MΦ polarization were associated with reduced phagocytosis and a more sparse distribution within the scar region. This resulted in impaired collagen deposition and fibrosis, and increased left ventricular remodelling and mortality in iRhom2-deficient mice after MI. Our findings reveal a requirement for an iRhom2-mediated proinflammatory response during downstream scarring and fibrosis, which is driven in part by TNF-α signaling. These conclusions challenge the existing model that infarct repair is determined exclusively by antiinflammatory signaling of M2 MΦs, and as such we propose an alternative view of immunomodulation to maintain effective healing after infarction.

Authors

Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley

×

Figure 8

Polarization and cytokine activation of BMDMs after in vitro stimulation.

Options: View larger image (or click on image) Download as PowerPoint
Polarization and cytokine activation of BMDMs after in vitro stimulation...
Bone marrow–derived macrophages (BMDMs) were stimulated for 16 hours with either LPS/IFN-γ or IL-4 to promote M1- or M2-like macrophages (MΦs), respectively. (A) iRhom2-mutant cells had increased M1 gene expression (Fcgr1 and Cd86) when stimulated with LPS/IFN-γ compared with controls, and reduced inhibition (Cd80) with IL-4 antiinflammatory stimulation. (B) Stimulation of iRhom2-deficient (iRhom2–/–) BMDMs with IL-4 activated M2 gene expression (Cd206 and Arg1) to a significantly greater extent than in wild-type controls. (C) iRhom2-mutant cells had increased M1 cytokines when treated with proinflammatory stimulation LPS/IFN-γ similar to controls, but relatively increased TNF-α expression with IL-4 stimulation. (D) iRhom2–/– MΦs revealed similar induction of TGF-β1, and increased IL-10, under proinflammatory (LPS/IFN-γ) conditions, compared with control cells. Data are shown as the mean ± SEM, n = 3 for each experimental group. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, 1-way ANOVA and post-hoc test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts